Perbedaan Intan Baru Prana Tbk. dan Merck Tbk.: Intan Baru Prana Tbk. diperdagangkan di Rp63 (kapitalisasi pasar 103,18 M, volume 24 jam 799,4 rb), sedangkan Merck Tbk. diperdagangkan di Rp3.900 (kapitalisasi pasar 1,76 T, volume 24 jam 63 rb). Perbedaan utamanya: Merck Tbk. jauh lebih besar — sekitar 17,1× kapitalisasi pasar Intan Baru Prana Tbk., dan Intan Baru Prana Tbk. lebih aktif diperdagangkan (799,4 rb vs 63 rb). Mana yang lebih baik tergantung tujuan investasimu.
| IBFN | MERK | |
|---|---|---|
Kapitalisasi Pasar | 103,18 M | 1,76 T |
Volume | 799,4 rb | 63 rb |
Lot | 7,99 rb | 630 |
Perputaran | — | 243,97 jt |
Harga Rata-rata | — | 3.872,46 |
Nilai Transaksi | — | 243,97 jt |
Harga Ekuilibrium Indikatif | — | 3.900 |
Volume Ekuilibrium Indikatif | — | 1 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Intan Baruprana Finance Tbk (the Company) was established based on Notarial Deed No. 19 dated September 4, 1991 and amended by Notarial Deed No. 121 dated June 16, 1993 of Esther Daniar Iskandar, S.H., notary in Jakarta. The Company started its commercial operations in 1997. The Company is part of the Intraco Penta group of companies.
Selengkapnya di halaman IBFN →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →